Resmed Inc. Stock
Price
Target price
€202.50
€202.50
0.000%
-
0.000%
€207.72
08:06 / Tradegate
WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Resmed Inc. Stock
There is no change in the price for Resmed Inc. today.
Resmed Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
As a result the target price of 207 € shows a slightly positive potential of 2.22% compared to the current price of 202.5 € for Resmed Inc..
Pros and Cons of Resmed Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 0.000% | 19.575% | 10.294% | -7.407% | 29.187% | 16.816% | 130.533% |
| QuidelOrtho Corp. | 0.540% | 1.087% | -16.498% | -54.423% | -45.149% | -58.080% | - |
| Boston Scientific | 0.000% | 6.250% | 7.188% | 43.763% | 32.193% | 87.070% | 104.943% |
| Waters Corp. | 0.590% | 5.210% | -9.125% | 6.912% | -3.709% | 15.397% | 52.044% |
Comments
ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $224.00 to $236.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
News
Why ResMed Stock Is Soaring Today
Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal 2024
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side).
Some good news from a clinical trial conducted by Eli Lilly
Why ResMed Stock Is Jumping Today
Shares of ResMed (NYSE: RMD) were jumping 7% as of 11:25 a.m. ET on Thursday after rising as much as 10.6% earlier in the morning. The solid gain came after the medical device maker announced